Retrospective Cohort Study to Investigate the Safety and Efficacy of Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)
Sponsor study identifier
observational
28
0 countries
N/A
Study Start
December 9, 2014
Actual (reported)Primary Completion
June 3, 2015
Actual (reported)Study Completion
June 3, 2015
Actual (reported)Retrospective study of CTX patients to investigate the safety and clinical efficacy of Chenodeoxycholic Acid
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 3, 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 9, 2014
Actual (reported)June 3, 2015
Actual (reported)June 3, 2015
Actual (reported)August 10, 2022
Actual (reported)August 12, 2022
Actual (reported)Serum Cholestanol Levels
34 years
Bile acid
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
CTX patients
Contact the study team to confirm eligibility.
28 participants (actual enrollment reported by the registry).
First Submitted
August 10, 2022
First Posted
August 12, 2022
Study Start
December 9, 2014
Actual (reported)Primary Completion
June 3, 2015
Actual (reported)Study Completion
June 3, 2015
Actual (reported)Last Updated
August 12, 2022
Record last verified: 2022-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: